Sanofi Canada Congratulates HPIC in Reaching $400M Milestone
Health Partners International of Canada (HPIC) recently celebrated the milestone of $400 million in donated medicines and hospital supplies to the developing world. Donations from Canadian pharmaceutical companies include prescription and over-the-counter medicines, vitamins, vaccines and hospital supplies. Sanofi Canada is proud to be one of the founding partners of HPIC.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi companies in Canada include Sanofi Canada (pharmaceuticals), Sanofi Pasteur (vaccines), Sanofi Consumer Health (health and beauty), Genzyme (rare diseases) and Merial (animal health). Together they employ more than 1,700 people, mainly in the greater Montreal and Toronto areas. In 2011 Sanofi companies invested $151.7 million in R&D in Canada, creating jobs, business and opportunity throughout the country.
*This press release was orginally published on Health Partners International of Canada